Should you be worried about WeWork India’s ₹3,000cr IPO?

WeWork India’s 3, 000 crore initial public offering (IPO) has come under the scanner of proxy advisory firm InGovern. Continue reading Should you be worried about WeWork India’s ₹3,000cr IPO?

Should you be worried about WeWork India’s ₹3,000cr IPO?

WeWork India’s 3, 000 crore initial public offering (IPO) has come under the scanner of proxy advisory firm InGovern. Continue reading Should you be worried about WeWork India’s ₹3,000cr IPO?

Gold rally lifts Philippine dollar reserves to 11-month high

MANILA, Philippines — The Philippines’ gross international reserves rose to $108.8 billion in September, the highest in 11 months, as higher gold prices boosted the value of the central bank’s holdings. The figure climbed from $107.1 billion in August, reflecting gains from global gold prices, investment income, and foreign currency deposits by the national government, Continue reading Gold rally lifts Philippine dollar reserves to 11-month high

Global Fintech Fest 2025 Kicks Off In Mumbai Today: What To Expect

A highlight of this year’s event is the keynote address by Prime Minister Narendra Modi and UK Prime Minister Keir Starmer on Thursday, where both leaders will engage with industry experts, policymakers, and innovators to discuss the future of fintech. Continue reading Global Fintech Fest 2025 Kicks Off In Mumbai Today: What To Expect

US Banks Are Taking Aim at a European Weak Spot

All’s fair in love and politics — and international bank capital rules. US financial watchdogs are making mischief with European standards that give lenders relief by treating the euro zone as a single domestic market. The Americans have a point: The bloc is not a single market for banking and that’s been a problem when things go wrong. But they doubtless have an ulterior motive born of the political obstacles to reforming some of their own rules to help big US banks compete harder with their Eu Continue reading US Banks Are Taking Aim at a European Weak Spot

Toyota Financial offers P 2-B bonds at nearly 6% yield

MANILA, Philippines – The automotive financing and leasing arm of GT Capital Holdings Inc. will raise P2 billion from the debt market as it anticipates broad asset growth and aims for a wider investor base. In a regulatory filing on Monday, GT Capital said the maiden bond offer of Toyota Financial Services Philippines Corp. (TFSPH) Continue reading Toyota Financial offers P 2-B bonds at nearly 6% yield

T-bill rates up ahead of inflation data, BSP meet

MANILA, Philippines – Yields on short-dated government debts went up during Monday’s sale of Treasury bills (T-bills) as investors await the inflation data and the central bank’s next policy decision this week. Auction results showed the Bureau of the Treasury was able to raise its target amount of P22 billion via T-bills. READ: Sept. inflation Continue reading T-bill rates up ahead of inflation data, BSP meet

As problems compound, Q2’s modest revenue growth won’t move the needle for battered IT stocks

The IT sector is poised for modest sequential revenue growth in Q2 FY26, hampered by continued client caution on discretionary spending and rising US protectionism. Continue reading As problems compound, Q2’s modest revenue growth won’t move the needle for battered IT stocks

Maynilad secures UK support for IPO

MANILA, Philippines – Maynilad Water Services Inc. has secured the support of the United Kingdom for its upcoming stock market debut, signaling strong demand for what would be the country’s largest—and last—initial public offering (IPO) this year. In its preliminary prospectus dated Oct. 3, Maynilad said it now had a cornerstone investment agreement with the Continue reading Maynilad secures UK support for IPO

BioCryst Sells European ORLADEYO Business for $250M Upfront to Focus on US Market

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best stocks to buy under $20. On October 1, BioCryst Pharmaceuticals announced the successful completion of the previously announced sale of its European ORLADEYO (berotralstat) business to Neopharmed Gentili. The transaction is valued at $250 million upfront, subject to customary purchase price adjustments, with the potential for […] Continue reading BioCryst Sells European ORLADEYO Business for $250M Upfront to Focus on US Market